Browsing by Author
Haslemo, Tore
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) | Type | М-cat. |
| 2021 | A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram | Braten, Line Skute; Haslemo, Tore; Jukic, Marin M   ; Ivanov, Maxim; Ingelman-Sundberg, Magnus; Molden, Espen; Kringen, Marianne Kristiansen | Article | |
| 2019 | Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study | Jukić, Marin ; Smith, Robert L.; Haslemo, Tore; Molden, Espen; Ingelman-Sundberg, Magnus | Article | |
| 2018 | Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients | Jukić, Marin ; Haslemo, Tore; Molden, Espen; Ingelman-Sundberg, Magnus | Article | |
| 2020 | Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients | Braten, Line Skute; Haslemo, Tore; Jukic, Marin M ; Ingelman-Sundberg, Magnus; Molden, Espen; Kringen, Marianne Kristiansen | Article | |
| 2019 | Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients | Haslemo, Tore; Eliasson, Erik; Jukić, Marin ; Ingelman-Sundberg, Magnus; Molden, Espen | Article | |